{"pub_date": "2016-01-21T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "Mr. Shkreli, a former Turing chief executive who has been criticized over drug pricing, was called to appear for a hearing to discuss pricing trends.", "print_page": "2", "document_type": "article", "byline": {"contributor": "Andrew Pollack contributed reporting.", "person": [{"rank": 1, "organization": "", "lastname": "GOLDSTEIN", "firstname": "Matthew", "role": "reported"}], "original": "By MATTHEW GOLDSTEIN"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 447, "url": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "447", "xlarge": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/01/21/business/21Shkrelisub/21Shkrelisub-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Congress Calls Shkreli to Testify on Rapid Rises in Drug Pricing", "main": "Congress Calls Martin Shkreli to Testify on Rapid Rises in Drug Pricing"}, "source": "The New York Times", "blog": [], "word_count": "848", "web_url": "http://www.nytimes.com/2016/01/21/business/dealbook/congress-subpoenas-martin-shkreli-over-drug-prices.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Mr. Shkreli, a former Turing chief executive who has been criticized over drug pricing, was called to appear for a hearing to discuss pricing trends.", "_id": "569fe66a38f0d80627b20ab9", "abstract": "Turing Pharmaceuticals founder Martin Shkreli is served subpoena to appear before House Committee on Oversight and Government Reform to discuss pricing trends and other developments in drug industry; it is unclear whether Shkreli, who has been charged with securities fraud, will show up to testify.", "keywords": [{"rank": "1", "name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y"}, {"rank": "2", "name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "4", "name": "organizations", "value": "House Committee on Oversight and Government Reform", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N"}, {"rank": "6", "name": "subject", "value": "Securities and Commodities Violations", "is_major": "N"}]}